MYELODYSPLASTIC SYNDROME (MDS)
Clinical trials for MYELODYSPLASTIC SYNDROME (MDS) explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROME (MDS) trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME (MDS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to extend life in High-Risk MDS
Disease control OngoingThis phase 3 study tests whether adding venetoclax to standard azacitidine helps people with newly diagnosed, higher-risk myelodysplastic syndrome (MDS) live longer. About 500 adults worldwide will receive either the combination or azacitidine alone. The main goal is to see if th…
Matched conditions: MYELODYSPLASTIC SYNDROME (MDS)
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
Could a targeted drug boost transplant success in tough blood cancers?
Disease control OngoingThis early-phase study tests whether adding the drug venetoclax to standard transplant preparation and post-transplant maintenance can safely help prevent cancer return in people with high-risk acute myeloid leukemia, myelodysplastic syndromes, or related blood cancers. About 102…
Matched conditions: MYELODYSPLASTIC SYNDROME (MDS)
Phase: PHASE1 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Scientists seek blood samples to unlock cancer secrets
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood and bone marrow samples from 550 people with blood cancers like leukemia and lymphoma. Researchers will study the samples in the lab to learn more about how these cancers work and find new ways to treat them. Participants only give samples when already n…
Matched conditions: MYELODYSPLASTIC SYNDROME (MDS)
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 17, 2026 01:59 UTC